Tvardi Therapeutics (TVRD) Payables: 2013-2015
Historic Payables for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2015 value amounting to $5.3 million.
- Tvardi Therapeutics' Payables rose 170.71% to $5.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was $14.3 million, marking a year-over-year increase of 29.85%. This contributed to the annual value of $5.3 million for FY2015, which is 170.71% up from last year.
- As of Q4 2015, Tvardi Therapeutics' Payables stood at $5.3 million, which was up 56.14% from $3.4 million recorded in Q3 2015.
- Tvardi Therapeutics' Payables' 5-year high stood at $5.3 million during Q4 2015, with a 5-year trough of $1.9 million in Q4 2014.
- Moreover, its 3-year median value for Payables was $2.5 million (2014), whereas its average is $3.0 million.
- Within the past 5 years, the most significant YoY rise in Tvardi Therapeutics' Payables was 170.71% (2015), while the steepest drop was 18.68% (2015).
- Quarterly analysis of 3 years shows Tvardi Therapeutics' Payables stood at $2.0 million in 2013, then fell by 0.61% to $1.9 million in 2014, then spiked by 170.71% to $5.3 million in 2015.
- Its Payables stands at $5.3 million for Q4 2015, versus $3.4 million for Q3 2015 and $3.1 million for Q2 2015.